Ioxaglate Meglumine and Ioxaglate Sodium

Ioxaglate Meglumine and Ioxaglate Sodium Brand Name– Hexabrix

What is Ioxaglate Meglumine and Ioxaglate Sodium

Ioxaglate Meglumine and Ioxaglate Sodium is an iodinated, ionic radiographic contrast agent indicated for pediatric angiocardiography, selective coronary arteriography with and without left ventriculography, peripheral arteriography, aortography, selective visceral arteriography, cerebral angiography, intravenous and intra-arterial digital subtraction angiography, peripheral venography, excretory urography, contrast enhancement of computed tomography (CT) head and body images, arthrography, and hysterosalpingography.

Avoid inadvertent intrathecal administration as this can result in serious adverse events, including death.

Serious and potentially fatal adverse events (i.e., cardiovascular toxicities, hypersensitivity reactions, severe cutaneous adverse reactions, acute renal failure) may also occur during intravascular use.

To minimize the toxicity risk, ensure the patients are adequately hydrated and use the smallest necessary volume and concentration of ioxaglate meglumine; ioxaglate sodium.

Indications

  1. angiography
  2. arthrography
  3. computed tomography (CT) imaging
  4. digital subtraction angiography (DSA)
  5. hysterosalpingography
  6. urography

Side Effects

  1. abdominal pain
  2. acute generalized exanthematous pustulosis (AGEP)
  3. amnesia
  4. anaphylactic shock
  5. anaphylactoid reactions
  6. angina
  7. angioedema
  8. aphasia
  9. arachnoiditis
  10. arthralgia
  11. bradycardia
  12. bronchospasm
  13. cardiac arrest
  14. cerebral edema
  15. chills
  16. coma
  17. confusion
  18. disseminated intravascular coagulation (DIC)
  19. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
  20. ecchymosis
  21. erythema
  22. fever
  23. flushing
  24. hallucinations
  25. headache
  26. hematoma
  27. hypertension
  28. hyperthermia
  29. hyperthyroidism
  30. hypotension
  31. hypothyroidism
  32. injection site reaction
  33. laryngospasm
  34. maculopapular rash
  35. myocardial infarction
  36. nasal congestion
  37. nausea
  38. nephrotoxicity
  39. paresis
  40. peripheral vasodilation
  41. phlebitis
  42. pruritus
  43. rash
  44. rhabdomyolysis
  45. seizures
  46. skin necrosis
  47. sneezing
  48. Stevens-Johnson syndrome
  49. stroke
  50. syncope
  51. thrombosis
  52. thyrotoxicosis
  53. toxic epidermal necrolysis
  54. urticaria
  55. ventricular fibrillation
  56. visual impairment
  57. vomiting

Monitoring Parameters

  • serum creatinine/BUN

Contraindications

  • asthma
  • atopy
  • breast-feeding
  • cardiac disease
  • cerebrovascular disease
  • children
  • coagulopathy
  • dehydration
  • diabetes mellitus
  • emphysema
  • extravasation
  • females
  • heart failure
  • hepatic disease
  • hypertension
  • hyperthyroidism
  • hypothyroidism
  • infants
  • infection
  • intrathecal administration
  • iodine hypersensitivity
  • migraine
  • multiple myeloma
  • neonates
  • pheochromocytoma
  • pregnancy
  • premature neonates
  • pulmonary disease
  • pulmonary hypertension
  • QT prolongation
  • radiation exposure
  • radiopaque contrast media hypersensitivity
  • renal disease
  • renal failure
  • renal impairment
  • serious rash
  • sickle cell disease
  • thromboembolic disease
  • thyroid disease
  • thyrotoxicosis
  • valvular heart disease

Interactions

  • Acetaminophen; Chlorpheniramine; Dextromethorphan; Phenylephrine
  • Acetaminophen; Chlorpheniramine; Phenylephrine; Phenyltoloxamine
  • Acetaminophen; Dextromethorphan; Guaifenesin; Phenylephrine
  • Acetaminophen; Dextromethorphan; Phenylephrine
  • Acetaminophen; Guaifenesin; Phenylephrine
  • Acyclovir
  • Aldesleukin, IL-2
  • Alogliptin; Metformin
  • Brompheniramine; Carbetapentane; Phenylephrine
  • Brompheniramine; Dextromethorphan; Phenylephrine
  • Canagliflozin; Metformin
  • Carbetapentane; Chlorpheniramine; Phenylephrine
  • Carbetapentane; Diphenhydramine; Phenylephrine
  • Carbetapentane; Guaifenesin; Phenylephrine
  • Carbetapentane; Phenylephrine
  • Carbetapentane; Phenylephrine; Pyrilamine
  • Carbinoxamine; Hydrocodone; Phenylephrine
  • Carbinoxamine; Phenylephrine
  • Chlophedianol; Guaifenesin; Phenylephrine
  • Chlorpheniramine; Dextromethorphan; Phenylephrine
  • Chlorpheniramine; Dihydrocodeine; Phenylephrine
  • Chlorpheniramine; Hydrocodone; Phenylephrine
  • Chlorpheniramine; Phenylephrine
  • Codeine; Phenylephrine; Promethazine
  • Dapagliflozin; Metformin
  • Dextromethorphan; Diphenhydramine; Phenylephrine
  • Dextromethorphan; Guaifenesin; Phenylephrine
  • Diphenhydramine; Hydrocodone; Phenylephrine
  • Diphenhydramine; Phenylephrine
  • Dopamine
  • Droxidopa
  • Empagliflozin; Linagliptin; Metformin
  • Empagliflozin; Metformin
  • Enflurane
  • Ephedrine
  • Ertugliflozin; Metformin
  • Ethanol
  • Etomidate
  • Fospropofol
  • General anesthetics
  • Glipizide; Metformin
  • Glyburide; Metformin
  • Guaifenesin; Phenylephrine
  • Halothane
  • Hydrocodone; Phenylephrine
  • Isoflurane
  • Ketamine
  • Linagliptin; Metformin
  • Metformin
  • Metformin; Pioglitazone
  • Metformin; Repaglinide
  • Metformin; Rosiglitazone
  • Metformin; Saxagliptin
  • Metformin; Sitagliptin
  • Midodrine
  • Nonsteroidal antiinflammatory drugs
  • Norepinephrine
  • Oxaliplatin
  • Phenylephrine
  • Phenylephrine; Promethazine
  • Propofol
  • Sevoflurane
  • Sodium Iodide
  • Valacyclovir
  • Vasopressors
15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856